The Lagos Zonal Directorate I of the Economic and Financial Crimes Commission (EFCC) on Wednesday, December 3, 2025, arraigned one Gabriel Celestine Nwawuzor and Moonlink Pharmaceuticals Limited before Justice Daniel Osiagor of the Federal High Court, Ikoyi, Lagos, over an alleged ₦55 million fraud.
Nwawuzor and the company were brought before the court on a three-count charge bordering on fraud and money laundering involving the sum of ₦55,000,000.
One of the charges alleges that Nwawuzor and Moonlink Pharmaceuticals, in April 2021, procured a Zenith Bank account (No. 2170235882) to retain ₦55 million believed to be proceeds of unlawful activity, an offence contrary to Sections 21(a) and 18(2)(d) of the Money Laundering (Prevention and Prohibition) Act, 2022, and punishable under Section 18(3).
Another count accuses the defendants of disguising the origin of the same ₦55 million by using it to purchase a property located at No. 23 Okenwa Okolo Street, Opana, Asaba, Delta State, contrary to Section 18(2)(a) of the Act.
Nwawuzor pleaded not guilty to all the charges.
Following his plea, prosecution counsel S.I. Suleiman requested a trial date and asked the court to remand the defendant in a correctional facility pending the commencement of trial.
However, defence counsel applied for bail, urging the court to admit the defendant on liberal terms.
Justice Osiagor granted bail in the sum of ₦100 million with two sureties in like sum, but ordered that Nwawuzor be remanded at the Nigerian Correctional Service (NCoS) facility until he meets the bail conditions.
The case was adjourned to March 11 and 12, 2026, for trial.
